Showing 146 Results
In this issue: Evidence and drug pricing policy, wages and access to care, the (minimal) costs of expanding pre-deductible coverage.
In this issue: Improving benefit design, patient perspectives on innovation, resources to guide health spending research and policy-making & more.
In this issue: Measuring the impact of innovation, new resources to navigate health spending research and policy-making, good practices for HDHPs and a busy spring event calendar.
In this issue: We offer a new resource on the myth of the "average" patient, outline key challenges in value assessment and health technology assessment, and highlight two upcoming webinars.
In this issue: Explore the pitfalls in the most recent drug pricing deal, regulation that's led to improvements in employee benefits and keys to improving equity in health coverage.
In 2020, NPC continued to drive discussions surrounding some of the most complex topics in health care policy through research, education and partnerships. Learn more in our annual report.
In this issue: Explore drug pricing and innovation, patient input in health benefit design, the research infrastructure to examine social determinants of health and upcoming events.
In this issue: meet NPC's new president and CEO, learn how we can tackle low-value care, what we need to know about the budget cap dilemma, and catch up on news you might have missed!
Dan Leonard is leaving as head of the National Pharmaceutical Council, effective Sept. 4.